355 related articles for article (PubMed ID: 18718909)
1. Induction of pyruvate dehydrogenase kinase-3 by hypoxia-inducible factor-1 promotes metabolic switch and drug resistance.
Lu CW; Lin SC; Chen KF; Lai YY; Tsai SJ
J Biol Chem; 2008 Oct; 283(42):28106-14. PubMed ID: 18718909
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of pyruvate dehydrogenase kinase 3 increases drug resistance and early recurrence in colon cancer.
Lu CW; Lin SC; Chien CW; Lin SC; Lee CT; Lin BW; Lee JC; Tsai SJ
Am J Pathol; 2011 Sep; 179(3):1405-14. PubMed ID: 21763680
[TBL] [Abstract][Full Text] [Related]
3. Metabolic enzyme PDK3 forms a positive feedback loop with transcription factor HSF1 to drive chemoresistance.
Xu J; Shi Q; Xu W; Zhou Q; Shi R; Ma Y; Chen D; Zhu L; Feng L; Cheng AS; Morrison H; Wang X; Jin H
Theranostics; 2019; 9(10):2999-3013. PubMed ID: 31244938
[No Abstract] [Full Text] [Related]
4. Targeting Hypoxia-Inducible Factor-1α/Pyruvate Dehydrogenase Kinase 1 Axis by Dichloroacetate Suppresses Bleomycin-induced Pulmonary Fibrosis.
Goodwin J; Choi H; Hsieh MH; Neugent ML; Ahn JM; Hayenga HN; Singh PK; Shackelford DB; Lee IK; Shulaev V; Dhar S; Takeda N; Kim JW
Am J Respir Cell Mol Biol; 2018 Feb; 58(2):216-231. PubMed ID: 28915065
[TBL] [Abstract][Full Text] [Related]
5. Expression of AGPAT2, an enzyme involved in the glycerophospholipid/triacylglycerol biosynthesis pathway, is directly regulated by HIF-1 and promotes survival and etoposide resistance of cancer cells under hypoxia.
Triantafyllou EA; Georgatsou E; Mylonis I; Simos G; Paraskeva E
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):1142-1152. PubMed ID: 29908837
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1.
Kim JW; Gao P; Liu YC; Semenza GL; Dang CV
Mol Cell Biol; 2007 Nov; 27(21):7381-93. PubMed ID: 17785433
[TBL] [Abstract][Full Text] [Related]
7. Impairment of HIF-1α-mediated metabolic adaption by NRF2-silencing in breast cancer cells.
Lee S; Hallis SP; Jung KA; Ryu D; Kwak MK
Redox Biol; 2019 Jun; 24():101210. PubMed ID: 31078780
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of the HIF-1α/PDK3 signaling axis drives melanoma toward mitochondrial oxidative metabolism and potentiates the therapeutic activity of pro-oxidants.
Kluza J; Corazao-Rozas P; Touil Y; Jendoubi M; Maire C; Guerreschi P; Jonneaux A; Ballot C; Balayssac S; Valable S; Corroyer-Dulmont A; Bernaudin M; Malet-Martino M; de Lassalle EM; Maboudou P; Formstecher P; Polakowska R; Mortier L; Marchetti P
Cancer Res; 2012 Oct; 72(19):5035-47. PubMed ID: 22865452
[TBL] [Abstract][Full Text] [Related]
9. The human HIF (hypoxia-inducible factor)-3alpha gene is a HIF-1 target gene and may modulate hypoxic gene induction.
Tanaka T; Wiesener M; Bernhardt W; Eckardt KU; Warnecke C
Biochem J; 2009 Oct; 424(1):143-51. PubMed ID: 19694616
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning.
Semenza GL
Biochim Biophys Acta; 2011 Jul; 1813(7):1263-8. PubMed ID: 20732359
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
Gong T; Cui L; Wang H; Wang H; Han N
J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
[TBL] [Abstract][Full Text] [Related]
12. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia.
Kim JW; Tchernyshyov I; Semenza GL; Dang CV
Cell Metab; 2006 Mar; 3(3):177-85. PubMed ID: 16517405
[TBL] [Abstract][Full Text] [Related]
13. Acetate supplementation restores chromatin accessibility and promotes tumor cell differentiation under hypoxia.
Li Y; Gruber JJ; Litzenburger UM; Zhou Y; Miao YR; LaGory EL; Li AM; Hu Z; Yip M; Hart LS; Maris JM; Chang HY; Giaccia AJ; Ye J
Cell Death Dis; 2020 Feb; 11(2):102. PubMed ID: 32029721
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia induces PDK4 gene expression through induction of the orphan nuclear receptor ERRγ.
Lee JH; Kim EJ; Kim DK; Lee JM; Park SB; Lee IK; Harris RA; Lee MO; Choi HS
PLoS One; 2012; 7(9):e46324. PubMed ID: 23050013
[TBL] [Abstract][Full Text] [Related]
15. BCL-xL is a target gene regulated by hypoxia-inducible factor-1{alpha}.
Chen N; Chen X; Huang R; Zeng H; Gong J; Meng W; Lu Y; Zhao F; Wang L; Zhou Q
J Biol Chem; 2009 Apr; 284(15):10004-12. PubMed ID: 19211554
[TBL] [Abstract][Full Text] [Related]
16. Specific inhibition of hypoxia inducible factor 1 exaggerates cell injury induced by in vitro ischemia through deteriorating cellular redox environment.
Guo S; Miyake M; Liu KJ; Shi H
J Neurochem; 2009 Mar; 108(5):1309-21. PubMed ID: 19183269
[TBL] [Abstract][Full Text] [Related]
17. Suppression of dual-specificity phosphatase-2 by hypoxia increases chemoresistance and malignancy in human cancer cells.
Lin SC; Chien CW; Lee JC; Yeh YC; Hsu KF; Lai YY; Lin SC; Tsai SJ
J Clin Invest; 2011 May; 121(5):1905-16. PubMed ID: 21490398
[TBL] [Abstract][Full Text] [Related]
18. The effect of HIF-1α on glucose metabolism, growth and apoptosis of pancreatic cancerous cells.
He G; Jiang Y; Zhang B; Wu G
Asia Pac J Clin Nutr; 2014; 23(1):174-80. PubMed ID: 24561986
[TBL] [Abstract][Full Text] [Related]
19. Silencing gastrin-releasing peptide receptor suppresses key regulators of aerobic glycolysis in neuroblastoma cells.
Rellinger EJ; Romain C; Choi S; Qiao J; Chung DH
Pediatr Blood Cancer; 2015 Apr; 62(4):581-6. PubMed ID: 25630799
[TBL] [Abstract][Full Text] [Related]
20. Structural determinants for cross-talk between pyruvate dehydrogenase kinase 3 and lipoyl domain 2 of the human pyruvate dehydrogenase complex.
Tso SC; Kato M; Chuang JL; Chuang DT
J Biol Chem; 2006 Sep; 281(37):27197-204. PubMed ID: 16849321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
